The Latin America vaccine market is experiencing significant growth due to increasing immunization programs, the expansion of public health initiatives, and continuous vaccine innovation by leading pharmaceutical companies. Valued at USD 4472.01 million in 2024, the market is projected to reach USD 7354.11 million by 2034, growing at a CAGR of 5.10% during 2025–2034. This growth reflects...